The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis.
The silencing of the tumor suppressor gene O-6-methylguanine-DNA methyltransferase (MGMT) by promoter methylation commonly occurs in human cancers. The relationship between MGMT promoter methylation and gastric cancer (GC) remains inconsistent. This study aimed to evaluate the potential value of MGMT promoter methylation in GC patients. Electronic databases were searched to identify eligible studies. The pooled odds ratio (OR) and the corresponding 95% confidence interval (95% CI) were used to evaluate the effects of MGMT methylation on GC risk and clinicopathological characteristics. In total, 31 eligible studies including 2988 GC patients and 2189 nonmalignant controls were involved in meta-analysis. In the pooled analysis, MGMT promoter methylation was significantly associated with GC risk (OR = 3.34, P < 0.001) and substantial heterogeneity (P < 0.001). Meta-regression and subgroup analyses based on the testing method, sample material and ethnicity failed to explain the sources of heterogeneity. Interestingly, MGMT methylation showed a trend associated with gender, and methylation is lower in males compared with females (OR = 0.76, 95% CI = 0.56-1.03). We did not find a significant association in relation to tumor types, clinical stage, age status or H. pylori status in cancer (all P > 0.1). MGMT promoter methylation may be correlated with the prognosis of GCs in disease free survival (DFS) or overall survival (OS) for univariate analysis. MGMT promoter methylation may play a crucial role in the carcinogenesis and prognosis of GC. MGMT methylation was not correlated with tumor types, clinical stage, age status, H. pylori status. However, the result of the association of MGMT methylation and gender should be considered with caution.
The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315020, People's Republic of China.
Yong
Y
Ding
The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315020, People's Republic of China.
Qihua
Q
Yang
The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315020, People's Republic of China.
Bojun
B
Wang
The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315020, People's Republic of China.
Guoliang
G
Ye
The College of Foreign Studies, Ningbo University, Ningbo, Zhejiang, 315211, People's Republic of China.
Xiaoqiong
X
Tong
D019175:DNA Methylation; D015254:DNA Modification Methylases / Q000502:physiology*; D045643:DNA Repair Enzymes / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D011401:Promoter Regions, Genetic / Q000502:physiology*; D012737:Sex Factors; D013274:Stomach Neoplasms / Q000209:etiology / Q000473:pathology*; D025521:Tumor Suppressor Proteins / Q000502:physiology*
D025521:Tumor Suppressor Proteins; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes